Retail Sector

Pharmacy Services & Retail Drugstore Industry  

Data by Company within Pharmacy Services & Retail Drugstore Industry

  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Cvs Health Corporation $ 92,078 $ 339,204 $ 2,947 300,000
Mckesson Corporation $ 60,642 $ 284,040 $ 3,910 75,000
Amerisourcebergen Corp $ 36,783 $ 254,425 $ 1,682 44,000
Cardinal Health Inc $ 23,156 $ 205,012 $ 262 46,500
Walgreens Boots Alliance Inc $ 18,425 $ 133,291 $ -3,544 325,000
Covetrus Inc. $ 2,939 $ 4,649 $ -13 5,000
Herbalife Ltd $ 1,429 $ 5,042 $ 226 600
Nu Skin Enterprises Inc $ 1,142 $ 2,042 $ 70 4,600
Petiq Inc $ 575 $ 998 $ -37 3,500
111 Inc $ 397 $ 1,960 $ -55 3,238
Petmed Express Inc $ 221 $ 265 $ -3 193
Sharing Services Global Corporation $ 98 $ 14 $ -39 -
Alset Capital Acquisition Corp $ 69 - $ 1 -
Aixin Life International Inc $ 54 $ 4 $ -6 -
Bimi International Medical Inc $ 38 $ 27 $ -35 -
Rite Aid Corp $ 22 $ 23,730 $ -946 50,000
Cosmos Health Inc $ 19 $ 49 $ -14 -
Trees Corporation $ 18 $ 17 $ -12 -
Medavail Holdings Inc $ 10 $ 24 $ -46 10
Trxade Health Inc $ 5 $ 9 $ -4 -
Stemtech Corporation $ 4 $ 4 $ 14 -
China Jo jo Drugstores Holdings Inc $ 3 $ 149 $ -21 3,377
Can B Corp $ 1 $ 5 $ -14 -
Merion Inc. - $ 1 $ -1 -
Flowerkist Skin Care And Cosmetics Inc - - $ 2 -
Pharmacy Services & Retail Drugstore Industry $ 238,127 $ 1,254,948 $ 4,324 861,018
  Recent News from Pharmacy Services & Retail Drugstore Industry
Can B Corp

Can B Corp Reports Significant Losses of $-0.37 per Share, Reflecting Struggles in the Current Market

As a seasoned investor, I analyze financial reports rigorously, looking for patterns and insights that would aid in making informed decisions. This article aims to interpret the latest financial results of Can B Corp, shedding light on its dwindling performance and the subsequent impact on its share prices.
The financial interval ending June 30, 2023, reveals a concerning loss for Can B Corp. The company reported a loss of $-0.37 per share, showing a slight improvement over the previous year's loss of $-0.49 per share. However, it is a decline from the previous financial reporting period, where the loss stood at $-0.36 per share. Such losses illustrate the challenges faced by Can B Corp in the current market.

Stemtech Corporation

Stemtech Corporation Defies the Odds with Remarkable Resurgence in Revenue during Challenging Times

Stemtech Corporation, a company operating in the [relevant industry], has experienced significant fluctuations in its share prices over the last five trading days. With a downward trend of -7.21%, the company's shares now reflect a year-to-date performance decrease of -48.52%. These figures suggest a challenging period for Stemtech, raising questions about the future implications for the company.
1. Break-even in Q2 2023:
During the fiscal second quarter of 2023, Stemtech Corporation reached a break-even point of $0.00 per share, a significant improvement compared to the previous year's loss of $-0.56 per share. However, compared to the prior quarter's loss of $-0.04 per share, there seems to be a minimal improvement. This break-even situation indicates that Stemtech is making efforts to improve its financial performance.

Trxade Health Inc

1. Trxade Health Inc: Revenue Plummets in Q2 of 2023, Sparking Concerns for Company's Future2. Breaking News: Trxade Health Inc Sees Significant Dip in Q2 2023 Revenue, Raises Alarm Bells

Trxade Health Inc, a healthcare services company that operates an online marketplace for pharmaceuticals, recently released its second-quarter 2023 financial report. Unfortunately, the report shows a weak business performance, resulting in a significant increase in losses compared to the same period last year.
One of the key metrics that highlights this decline is the net loss per share, which surged to $-2.90 from $-0.13. This indicates a substantial decrease in profitability for the company. Additionally, the revenue for the second quarter fell by 29.009% to $2.25 million, compared to $3.17 million in the previous year. This decline in revenue further emphasizes the challenges faced by Trxade Health Inc during this period.

Bimi International Medical Inc

BIMI Reports Striking Revenue Slump Amidst Recent Fiscal Period, Raising Concerns Over Bimi International Medical Inc's Financial Position

BIMI Reports Disappointing Financial Results for Q1 2023: Future Performance Remains Uncertain
Bimi International Medical Inc (BIMI) recently disclosed its financial results for the interval ending March 31, 2023, which painted a disappointing picture for the company. Revenue experienced a significant decline of -36.299% to $3.20 million, while net loss per share reached $-0.23, as compared to $-0.27 in the first quarter of 2022.
This downturn stands in contrast to the remainder of the Pharmacy Services and Retail Drugstore sector, which saw a revenue improvement in the first quarter of 2023. In the previous reporting season, BIMI's EPS fell from $6.39 per share, while revenue turned positive from $-34,046.66 million.

Sharing Services Global Corporation

Sharing Services Global Corporation (SHRV) Faces Steep Revenue Decline and Net Loss ? What's Next for the Company?

Sharing Services Global Corporation (SHRV) recently released its first quarter financial report for 2024, which highlighted concerning figures in terms of revenue and net loss per share. However, it is important to compare these figures with previous periods and industry peers to gain a more comprehensive understanding of the company's situation. This article will examine the implications of SHRV's financial results and discuss how they may impact the company moving forward.
1. Revenue Meltdown and Net Loss Per Share:
SHRV's first quarter of 2024 saw revenue decline by a significant -45.733% to $2.88 million. Simultaneously, the net loss per share remained stagnant at $-0.01, which was identical to the previous financial period ending in June 2022. These figures indicate a worrying trend and pose a challenge for SHRV to reverse the declining revenue and bring about profitability.

Aixin Life International Inc

Pharmacy Services & Retail Drugstore Company, Aixin Life International Inc, Celebrates Strong Fiscal Performance with Balanced Books and Remarkable Revenue Growth in Q2 2023

Financial News Report: Aixin Life International Inc Achieves Balanced Books and Revenue Growth in Q2 2023
Aixin Life International Inc, a Pharmacy Services and Retail Drugstore company, has reported encouraging financial results for the April to June 30, 2023 fiscal period. The company achieved balanced books of $0.00 per share, compared to a loss of $-0.02 per share in the same period last year and in the prior financial reporting period.
Notably, Aixin Life International Inc witnessed a significant increase in revenue. The company's revenue surged by 250.701% to $1.48 million, up from $0.42 million in the corresponding period last year. Additionally, there was a sequential revenue growth of 95.579% from $0.75 million in the previous quarter.

Cardinal Health Inc

Cardinal Health Inc. Delivers Impressive Revenue Growth, but Investors Worry as Company Plunges into Deep Deficit

Cardinal Health Inc, a leading Pharmacy Services and Retail Drugstore company, recently released its financial results for the April to June 30, 2023 reporting season. While the company saw a significant increase in revenue, with a growth of 13.481% compared to the same period last year, it unfortunately slipped into a shortfall at $-0.27 per share.
In the previous reporting season, Cardinal Health Inc experienced a 5.875% increase in revenue from $50.49 billion, but its Income per Share fell from $1.34. This downward trend is concerning for investors and raises questions about the company's overall financial performance.

Cosmos Health Inc

Revitalizing the Future: Cosmos Health Inc.'s Astonishing Growth in Q2 of 2023

In the highly competitive world of healthcare, Cosmos Health Inc continues to face an uphill battle as it attempts to regain stability and turn its financial performance around. The recently released financial results for the timeframe closing June 30, 2023, illustrate the company's ongoing struggles. While there are a few positive signs, Cosmos Health Inc still has a lot of work to do to regain investor confidence and deliver consistent growth.
Revenue Decline and Improvements in Loss Per Share
According to the financial report, Cosmos Health Inc experienced a decline in revenue by 6.398%, with the figure dropping to $12.36 million from $13.21 million in the same period the previous year. However, sequentially, the revenue experienced a slight 0.111% increase from $12.35 million.

Medavail Holdings Inc

Medavail Holdings Inc Struggles with Sharp Revenue Decline and Increased Losses in Q2 2023

Medavail Holdings Inc, a Pharmacy Services and Retail Drugstore company, has recently released its second-quarter financial report for 2023. The results were disappointing, with revenue fading by -96.379% to $0.41 million compared to the same quarter last year. Additionally, the shortfall per share has extended to $-3.06, which is a significant increase from the previous reporting season.
However, despite Medavail Holdings' poor performance, the Pharmacy Services and Retail Drugstore sector as a whole recorded a revenue gain in the second quarter of 2023. This is a positive sign for the industry, but it highlights the struggles that Medavail Holdings is facing.

Trees Corporation

Trees Corporation Faces Growing Deficit During Q2 2023 Earnings Season

Trees Corporation, a company in the Pharmacy Services and Retail Drugstore industry, has recently released its earnings report for the second quarter of the 2023 fiscal year. Despite a widening deficit of -$0.02 per share compared to $0.00 a year ago and -$0.02 per share from the previous financial reporting period, the company has demonstrated promising growth in its revenue.
In the same financial reporting period a year ago, Trees Corporation's revenue saw a significant increase of 57.553% to $5.10 million from $3.24 million. However, sequentially, the revenue decreased by -0.247% from $5.11 million. Nonetheless, these figures indicate that Trees Corporation has outperformed its industry peers in terms of revenue growth, as the rest of the Pharmacy Services and Retail Drugstore industry reported only a 10.21% improvement during this period.


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com